Stock COOL CORE ONE LABS INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Core One Labs Inc.

Equities

COOL

CA21872J3073

Market Closed - Canadian Securities Exchange
Other stock markets
 10:51:37 2024-05-31 am EDT 		5-day change 1st Jan Change
0.18 CAD -5.26% Intraday chart for Core One Labs Inc. -2.70% -37.93%
Apr. 09 Core One Labs Inc. announced that it expects to receive CAD 1.5 million in funding CI
Feb. 29 Core One Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Core One Labs : Announces Extension of Non-Brokered Private Placement
PU
Core One Labs : Announces Non-Brokered Private Placement
PU
Core One Labs Inc. announced that it expects to receive CAD 1.5 million in funding
CI
Core One Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Core One Labs Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Core One Labs Inc. announced that it has received CAD 0.2 million in funding
CI
Core One Labs : Announces Non-Brokered Private Placement
PU
Core One Labs Inc. announced that it expects to receive CAD 1 million in funding
CI
Core One Labs Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Core One Labs : Commends Study Exploring Psychedelics’ Efficacy in Providing Relief for Chronic Pain Conditions
PU
Core One's Akome Reveals Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer?s and Parkinson's Disease
CI
Core One Labs : Applauds Groundbreaking Research on Psilocybin as a Potential Anorexia Treatment
PU
Core One Labs Inc. Reports Earnings Results for the Fifteen Months Ended March 31, 2023
CI
Core One Labs Inc.'s Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer?s and Parkinson?s Disease
CI
Core One Labs : Applauds California Assembly Health Committee’s Approval of Bill to Legalize Psychedelics
PU
Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process
MT
Core One's Vocan Files International Patent For Breakthrough Proprietary Biosynthetic Psilocybin Production Method
MT
Core One Labs Inc. Applauds FDA's Draft Guidance on Clinical Trials for Psychedelic Drugs
CI
Core One Labs : Applauds FDA’s Draft Guidance on Clinical Trials for Psychedelic Drugs
PU
Core One Labs Says in Talks with Multiple Companies to Supply Psilocybin; COOL Gained 15% on Friday
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. COOL Stock
  4. News Core One Labs Inc.